Development and promotion in translational medicine: perspectives from 2012 sino‐american symposium on clinical and translational medicine-Reference-Cited by-同舟云学术

Development and promotion in translational medicine: perspectives from 2012 sino‐american symposium on clinical and translational medicine

Published:2012-10-24 Issue:1 Volume:1 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Qian Mengjia¹,Wu Duojiao¹,Wang Ena²,Marincola Francesco M²,Wang Wei³⁴,Rhodes William⁵,Liebman Michael⁶,Bai Chunxue⁷,Lam Ching‐Wan⁸,Marko‐Varga Gyorgy⁹,Fehniger Thomas E⁹,Andersson Roland⁹,Wang Xiangdong⁷¹

Affiliation:

1. Biomedical Research CenterShanghaiChina

2. Infectious Disease and Immunogenetics Section (IDIS)Department of Transfusion MedicineClinical Center and Center for Human Immunology (CHI)NIHBethesdaMDUSA

3. School of Medical SciencesEdith Cowan UniversityPerthAustralia

4. Beijing Municipal Key Laboratory of Clinical EpidemiologyGraduate University of the Chinese Academy of SciencesBeijingChina

5. Becton Dickinson and CoFranklin LakesNew JerseyUSA

6. LLC and of Strategic Medicine, IncStrategic MedicineBVThe HagueNL

7. Department of Pulmonary MedicineFudan University School of MedicineZhongshan HospitalShanghaiChina

8. Department of PathologyThe University of Hong KongHong KongChina

9. Department of Surgery, Clinical Sciences, Medical FacultyLund UniversityLundSweden

Funder

Shanghai Consulting and Academic Activities Center for Academicians of Chinese Academy of Engineering

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/2001-1326-1-25

Reference19 articles.

1. New paradigms in translational science research in cancer biomarkers

2. Translational research in medical informatics or from theory to practice. A call for an applied informatics journal;Lehmann CU;Methods Inf Med,2008

3. Translational research

4. Translational Research: Moving Discovery to Practice

5. Chorus is an early phase drug development group that cost‐effectively advances candidate molecules from discovery through clinical Proof of Concept (PoC).http://www.choruspharma.com/.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stakeholder engagement analysis - a bioethics dilemma in patient-targeted intervention: patients with temporomandibular joint disorders;Journal of Translational Medicine;2015-01-20

2. Getting From the Bench to the Patient;Surgical Oncology Clinics of North America;2013-10